Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-096740
Filing Date
2025-07-17
Accepted
2025-07-17 20:47:51
Documents
1
Period of Report
2025-07-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3440
  Complete submission text file 0000950170-25-096740.txt   4811
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address
Castagna Michael (Reporting) CIK: 0001674282 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50865 | Film No.: 251132489